Deutsche Bank’s PROVECTUS BIOPHARMACEUTICALS, INC. (DE) PVCT Stock Holding History

Deutsche Bank’s Portfolio PVCT Stock Details PVCT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-2,000	Closed	–	–	5284
2016 Q3	$0	Hold	2,000	–	–	﹤0.01%	5464
2016 Q2	$0	Hold	2,000	–	–	﹤0.01%	5509
2016 Q1	$0	Hold	2,000	–	–	﹤0.01%	5491
2015 Q4	$0	Sell	2,000 -7,500	-79%	-$3.55K	﹤0.01%	5524
2015 Q3	$5K	Hold	9,500	–	–	﹤0.01%	5057
2015 Q2	$5K	Hold	9,500	–	–	﹤0.01%	5163
2015 Q1	$7K	Sell	9,500 -11,600	-55%	-$9.56K	﹤0.01%	4864
2014 Q4	$16K	Buy	21,100 +11,600	+122%	+$10.6K	﹤0.01%	5596
2014 Q3	$9K	Sell	9,500 -5,000	-34%	-$4.85K	﹤0.01%	5428
2014 Q2	$12K	Buy	+14,500	New	+$17.4K	﹤0.01%	5464

Other funds holding PVCT

CCB

Cutter & Co Brokerage Ballwin, Missouri $423M AUM 15.02% 1-Year Est. Return

HFBOT

Home Federal Bank of Tennessee Knoxville, Tennessee $463M AUM 24.62% 1-Year Est. Return

Deutsche Bank's PVCT Position: Q4 2016 in Review

Deutsche Bank sold out of PROVECTUS BIOPHARMACEUTICALS, INC. (DE) (PVCT) in Q4 2016, closing a stake of 2,000 shares.

Deutsche Bank first reported a position in PVCT in Q2 2014 and held it in 10 quarters. The position peaked at $16K in Q4 2014. 8 funds tracked by Wall St. Rank hold PVCT as of Q4 2016.

Deutsche Bank reported no remaining PROVECTUS BIOPHARMACEUTICALS, INC. (DE) position as of Q4 2016 after selling out during the quarter.
Deutsche Bank sold 2,000 PROVECTUS BIOPHARMACEUTICALS, INC. (DE) shares in Q4 2016.
Deutsche Bank first reported a position in PROVECTUS BIOPHARMACEUTICALS, INC. (DE) in Q2 2014 and held it in 10 quarters.
Deutsche Bank's PROVECTUS BIOPHARMACEUTICALS, INC. (DE) position peaked at $16K in Q4 2014.
8 funds tracked by Wall St. Rank held PROVECTUS BIOPHARMACEUTICALS, INC. (DE) as of Q4 2016.

Based on Deutsche Bank's 13F filing for Q4 2016, filed 14 Feb 2017.